Literature DB >> 18393161

Extensive brain swelling with neurological deterioration after intracranial meningioma surgery - venous complication or 'unspecific' increase in tissue permeability.

S Asgari1, H Bassiouni, A Hunold, D Klassen, D Stolke, I E Sandalcioglu.   

Abstract

OBJECTIVE: We retrospectively analyzed a series of patients who deteriorated after resection of an intracranial meningioma due to extensive brain edema (EBE) with regard to etiology of the neurological worsening and outcome.
METHODS: Out of a series of 376 consecutive patients who underwent resection of an intracranial meningioma, 13 (3.5%) experienced postoperative deterioration due to EBE which necessitated prolonged artificial ventilation, tracheal reintubation, or decompressive craniectomy. Clinical data, radiological findings, operative records and follow-up data of these patients were retrospectively reviewed.
RESULTS: The study revealed two different patient groups: Patients in group A (n=7) demonstrated edema due to typical venous infarction (VI). A decompressive craniotomy was performed in all but one patient in this group; nonetheless, an acceptable neurological outcome (Glasgow Outcome Scale (GOS) 4) was achieved in only two cases. Patients in group B (n=6) deteriorated due to an EBE of unknown etiology. Mean tumor volume in this group was higher when compared to group A (75 ml vs. 30 ml). In addition, 83% of patients in group B displayed extensive preoperative peritumoral edema compared to only 14% in group A. Three patients in group B required decompressive surgery; however, neurological outcome was more favorable in this group as 83% achieved a GOS of 4 or 5.
CONCLUSION: Extensive brain swelling during or after intracranial meningioma surgery may be due to VI or possibly due to increased postoperative tissue permeability. It is recommended to preserve all venous structures as patients with VI had an unfavorable neurological outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18393161     DOI: 10.1055/s-2007-992136

Source DB:  PubMed          Journal:  Zentralbl Neurochir        ISSN: 0044-4251


  7 in total

1.  Risk factors influencing cerebral venous infarction after meningioma resection.

Authors:  Qing Cai; Shoujie Wang; Min Zheng; Xuejiao Wang; Rong Liu; Liqin Liu; Huaizhou Qin; Dayun Feng
Journal:  BMC Neurol       Date:  2022-07-13       Impact factor: 2.903

2.  Reoperation as a result of raised intracranial pressure associated with cyst formation in tumor cavity after intracranial tumor resection: a report of two cases.

Authors:  Jinlu Yu; Wenji Xiong; Limei Qu; Haiyan Huang
Journal:  Case Rep Med       Date:  2010-09-28

Review 3.  Cerebral venous collaterals: A new fort for fighting ischemic stroke?

Authors:  Lu-Sha Tong; Zhen-Ni Guo; Yi-Bo Ou; Yan-Nan Yu; Xiao-Cheng Zhang; Jiping Tang; John H Zhang; Min Lou
Journal:  Prog Neurobiol       Date:  2017-12-02       Impact factor: 11.685

4.  A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas.

Authors:  Sirirat Tribuddharat; Thepakorn Sathitkarnmanee; Amnat Kitkhuandee; Sunchai Theerapongpakdee; Kriangsak Ngamsaengsirisup; Sarinya Chanthawong
Journal:  Drug Healthc Patient Saf       Date:  2016-02-09

5.  Emergency decompressive craniectomy after removal of convexity meningiomas.

Authors:  Paolo Missori; Maurizio Domenicucci; Sergio Paolini; Cristina Mancarella; Serena Tola; Alessandro D'Elia; Nicola Marotta; Arsen Seferi; Vincenzo Esposito
Journal:  Surg Neurol Int       Date:  2016-10-26

6.  Blood Flow and Continuous EEG Changes during Symptomatic Plateau Waves.

Authors:  Natalie Kreitzer; Maggie Huynh; Brandon Foreman
Journal:  Brain Sci       Date:  2018-01-12

7.  Three-Dimensional Radiomics Features From Multi-Parameter MRI Combined With Clinical Characteristics Predict Postoperative Cerebral Edema Exacerbation in Patients With Meningioma.

Authors:  Bing Xiao; Yanghua Fan; Zhe Zhang; Zilong Tan; Huan Yang; Wei Tu; Lei Wu; Xiaoli Shen; Hua Guo; Zhen Wu; Xingen Zhu
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.